Pharmasynthèse was granted by the French Health agency ANSM a new GMP certificate covering every APIs manufactured on-site in Saint Pierre les Elbeufs

  • Inabata France implemented the Good Distribution Practices (GDP) for distribution of APIs
  • Pharmasynthèse was granted a new CEP n° R0-CEP 2007-117-Rev00 by the European Health Agency for its leading active ingredient Dibucaïne, HCl

footer-logo1 footer-logo2